Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
MEK1/2 inhibitor.
Endogenous peptide hormone fragment, involved i...
Polyether pyrrole, divalent cation ionophore.
EGFR inhibitor.
ATP competitive CDK inhibitor.
L-type and T-type Ca2+ and TRP antagonist.
Indoline; PDGFR, VEGFR, c-KIT, FLT3, mTORC1 inh...
Synthetic ITC, erucin analog.
Endogenous peptide fragment, involved in vasoco...
Indirubin derivative.
Heterocyclic derivative of cysteine, alters pro...
5-Fluorouracil derivative, fluorinated pyrimidi...
Peptide hormone found in Solanaceae family plan...
p110δ PI3K inhibitor.
Histamine H2 antagonist, GSK-3β inhibitor.
Diterpene found in coffee beans.
5-HT2/3/6/7, D2/3/4, histamine H1, α1-adrenerg...
Triterpene saponin found in species of Panax.
Electron carrier used to study dehydrogenase el...
Purine derivative; CDK inhibitor.